Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience

Brain Research

Volumn 1294, Issue , 2009, Pages 29-37

  Baptista, Daniela ^a   Bussadori, Karina ^a   Nunes de Souza, Ricardo Luiz ^a,b   Canto de Souza, Azair ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Amygdala; Antinociception; Elevated plus maze; Fear; Mice; Midazolam

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACETIC ACID; MIDAZOLAM MALEATE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEAR; HISTOPATHOLOGY; INFUSION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; WRITHING TEST;

ACETIC ACID; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; CATHETERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; MALE; MAZE LEARNING; MICE; MICROINJECTIONS; MIDAZOLAM; PAIN; PAIN MEASUREMENT; TIME FACTORS;

MUS; RODENTIA;

EID: 70249119570     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.055     Document Type: Article

References (48)

1. Albrechet-Souza L., Oliveira A.R., De Luca M.C.Z., Tomazini F.M., Santos N.R., and Brandão M.L. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Prog. Neuropsychopharmacol. Biol. Psych. 29 (2005) 571-579
2. Albrechet-Souza L., Borelli K.G., and Brandão M.L. Activity of medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. J. Neurosci. Methods 169 (2008) 109-118
3. Barbalho C.A., Nunes-de-Souza R.L., and Canto-de-Souza A. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for endogenous benzodiazepine inverse agonist release in elevated plus-maze exposed mice. Brain Res. 1267 (2009) 65-76
4. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 72 (2002) 449-455
5. Bertoglio L.J., and Carobrez A.P. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 73 4 (2002) 963-969
6. Bertoglio L.J., and Carobrez A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats. Psychopharmacol. 170 (2003) 335-342
7. Bertoglio L.J., and Carobrez A.P. Scopolamine given pre-trial one prevents the one trial tolerance phenomenon in the elevated plus-maze trail 2. Behav. Pharmacol. 15 (2004) 45-54
8. Bolles R.C., and Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3 (1980) 291-322
9. Canto-de-Souza A., Nunes-de-Souza R.L., Pelá I.R., and Graeff F.G. High intensity social conflict in the Swiss albino mouse induces analgesia modulated by 5-HT1A receptors. Pharmacol. Biochem. Behav. 56 (1997) 481-486
10. Canto-de-Souza A., Nunes-de-Souza R.L., and Rodgers R.J. Anxiolytic-like effect of WAY-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience. Brain Res. 928 (2002) 50-59
11. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior. The elevated plus-maze model 20 years. Neurosc. Biobehav. Rev. 29 (2005) 1193-1205
12. Conceição I.M., Maiolini M., Mattia N., Vital M.A., Santos B.R., Smaili S., and Frussa-Filho R. Anxiety-induced antinociception in the mouse. Braz. J. Med. Biol. Res. 25 (1992) 831-834
13. Cornélio A.M., and Nunes-de -Souza R.L. Open elevated plus-maze induced antinociception in rats: A non-opioid type of pain inhibition?. Phys. Behav. 96 (2009) 440-447
14. Dal-Cól M.L.C., Orlandi Pereira L., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol. Biochem. Behav. 74 (2003) 395-400
15. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., and Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacol. 113 (1994) 570-572
16. Engin E., and Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 1399-1419
17. Fields H.L., Basbaum A.I., and Heinricher M.M. Central nervous system mechanisms of pain modulation. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's Textbook of Pain. 5th ed. (2006), Elsevier Churchill Livingstone 125-142
18. File S.E., and Zangrossi Jr H. "One trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze on the development of a phobic state?. Psychopharmacol. 110 (1993) 240-244
19. File S.E., Mabbutt P.S., and Toth E. A comparison of the effects of diazepam and scopolamine in two positively reinforced learning tasks. Pharmacol. Biochem. Behav. 37 (1990) 587-592
20. File S.E., Zangrossi H.J., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacol. 111 (1993) 491-494
21. Franklin K.B., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, California, USA
22. 1A) receptors located within the periaqueductal. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. doi:10.1016/j.pnpbp.2009.07.015.
23. Gonzalez L.E., and File S.E. A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosc. 17 4 (1997) 1505-1511
24. Griebel G., Rodgers R.J., Perrault G., and Sanger D.J. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze. Pharmacol. Biochem. Behav. 57 (1997) 817-827
25. Heinricher M.M., Tavares I., Leith J.L., and Lumb B.M. Descending control of nociception: specificity, recruitment and plasticity. Br. Res. Reviews 60 1 (2009) 214-225
26. Holmes A., and Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?. Pharmacol. Biochem. Behavior. 60 (1998) 473-488
27. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosc. and Biobehav. Reviews. 23 (1999) 971-980
28. Kelly D.D. Stress induced antinociception. Ann. N.Y. Acad. Sci. (1986) 467
29. Lee C., and Rodgers R.J. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacol. 102 (1990) 507-513
30. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacol. 92 (1987) 180-185
31. Mendes-Gomes J., and Nunes-de-Souza R.L. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice. Brain Res. 1047 (2005) 97-104
32. Mendes-Gomes, J., Nunes-de-Souza, R.L., 2009. Anxiolytic-like effects produced by bilateral lesion of the periaqueductal gray in mice: Influence of concurrent nociceptive stimulation. Behav. Brain Res. doi:10.1016/j.bbr.2009.04.032. References and further reading may be available for this article. To view references and further reading you must purchase this article.
33. Miczek K.A., Thompson M.L., and Shuster L. Opioid-like analgesia in defeat mice. Sci. 215 (1982) 1520-1522
34. Nunes-de-Souza R.L., Canto-de-Souza A., Fornari R.V., Costa M., Pelá I.R., and Graeff F.G. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacol. 150 (2000) 300-310
35. Nunes-de-Souza R.L., Canto-de-Souza A., and Rodgers R.J. Effects of intra-hippocampal infusion of WAY-1000635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Res. 927 (2002) 87-96
36. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in a elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14 (1985) 149-167
37. Rodgers R.J. Neuropharmacological aspects of adaptative pain inhibition in murine victims of aggression. Agress. Behav. 21 (1995) 29-39
38. Rodgers R.J., and Hendrie C.A. Social conflict activates status-dependent endogenous analgesic or hyperalgesic mechanisms in male mice: effects of naloxone on nociception and behaviour. Physiol. Behav. 30 (1983) 775-780
39. Rodgers R.J., and Randall J.I. Acute non-opioid analgesia in defeated male mice. Physiol. Behav. 36 (1986) 947-950
40. Rodgers R.J., and Randall J.I. Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice. Psychopharmacol. 91 (1987) 305-315
41. Rodgers R.J., and Shepherd J.K. Prevention of the analgesic consequences of social defeat in male mice by 5HT1A anxiolytics, buspirone, gepirone and ipsapirone. Psychopharmacol. 99 (1989) 374-380
42. Rodgers R.J., Shepherd J.K., and Randall J.I. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR 38032F, on non-opioid defeat analgesia in male mice. Neuropharmacol. 29 (1990) 17-23
43. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacol. 113 (1993) 237-242
44. Rodgers R.J., Johnson N.J.T., Carr J., and Hodgson T.P. Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav. Brain Res. 86 (1997) 71-77
45. Shepherd J.K., and Randall J.I. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR 38032F, on non-opioid defeat analgesia in male mice. Neuropharmacol. 29 (1990) 17-23
46. Siegfried B., Frischknecht H.R., and Nunes-de-Souza R.L. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci. Biobehav. Rev. 14 (1990) 481-490
47. Treit D., Pesold C., and Rotzinger S. Dissociating the anti-fear effects of septal and amygdala lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci. 107 (1993) 1-16
48. Vanderwende C., and Margolin S. Analgesic tests based upon experimentally induced acute abdominal pain in rats. Fed. Proc. 15 (1956) 494